By G HossainPosted on July 29, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Investors are focused on Incyte’s late-stage programs as the biotech braces for the 2028 patent cliff of its leading product Jakafi. Incyte cuts early-stage cancer drug to focus on next-gen programs Post navigation Novo ordered to face CagriSema fraud claims from shareholders: New Jersey courtDo you need oncology experience to land an oncology job?
